依达拉奉联合疏血通治疗急性脑梗死临床疗效研究

Study on the Clinical Curative Effect of Edaravone Combined With Shuxuetong Injection in Treatment of Acute Cerebral Infarction

目的评价急性脑梗死给予依达拉奉联合疏血通治疗的临床疗效。方法抽取86例急性脑梗死患者随机分成两组,各43例;对照组单用依达拉奉治疗,观察组给予依达拉奉联合疏血通治疗。结果在治疗总有效率上,观察组为93.02%,高于对照组的72.09%,两组数据差异有统计学意义(P<0.05)。治疗前,两组患者NIHSS评分差异无统计学意义(P>0.05);治疗后观察组NIHSS评分低于对照组(P<0.05)。结论急性脑梗塞患者给予依达拉奉联合疏血通治疗有确切疗效。

Objective Evaluation on acute cerebral infarction with clinical curative effect of edaravone combined with Shuxuetong injection therapy. Methods Extraction of 86 cases of patients with acute cerebral infarction were randomly divided into two groups,43 cases in each. The control group only treated with edaravone,the observation group was given treatment of edaravone combined with Shuxuetong injection. Results In the total effective rate ofthe observation group was 93.02%,significantly higher than that of the control group of 72.09%,the difference between the two groups was statistically significant（P〈0.05）. Before treatment, there was no significant difference in NIHSS scores between the two groups（P〉0.05）. After treatment,the NIHSS score of the observation group was significantly lower than that of the control group（P〈0.05）. Conclusion In patients with acute cerebral infarction treated with edaravone combined with Shuxuetong treatment has obvious curative effect.